Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Nucor Trades at Premium Valuation: Buy, Sell or Hold the Stock?
Nucor Trades at Premium Valuation: Buy, Sell or Hold the Stock?

Nucor Corporation NUE is currently trading at a forward price/earnings of 13.31X, a roughly 22% premium to the Zacks Steel Producers industry average of 10.9X. NUE is trading at a premium to Steel

Best Value Stocks to Buy for May 14th
Best Value Stocks to Buy for May 14th

Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 14th:  

Strattec Security STRT: This company which designs, develops, manufactures and

Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates
Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates

Verve Therapeutics (VERV) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.71. This compares to loss of $0.59 per share a year ago. These figures

Chicago Atlantic BDC, Inc. (LIEN) Reports Q1 Loss, Lags Revenue Estimates
Chicago Atlantic BDC, Inc. (LIEN) Reports Q1 Loss, Lags Revenue Estimates

Chicago Atlantic BDC, Inc. (LIEN) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of $0.34. This compares to loss of $0.01 per share a year ago. These figures

ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Lags Revenue EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Lags Revenue Estimates

ARS Pharmaceuticals, Inc. (SPRY) came out with a quarterly loss of $0.35 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.11 per share a year ago. These figures are

Cellebrite DI Ltd. (CLBT) Tops Q1 Earnings Estimates
Cellebrite DI Ltd. (CLBT) Tops Q1 Earnings Estimates

Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.08 per share a year ago. These

Bitfarms Ltd. (BITF) Reports Q1 Loss, Tops Revenue Estimates
Bitfarms Ltd. (BITF) Reports Q1 Loss, Tops Revenue Estimates

Bitfarms Ltd. (BITF) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.02 per share a year ago. These figures are adjusted for

Kamada (KMDA) Q1 Earnings Match Estimates
Kamada (KMDA) Q1 Earnings Match Estimates

Kamada (KMDA) came out with quarterly earnings of $0.07 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for

Radcom (RDCM) Q1 Earnings and Revenues Top Estimates
Radcom (RDCM) Q1 Earnings and Revenues Top Estimates

Radcom (RDCM) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.18 per share a year ago. These figures are

Zacks Industry Outlook Highlights Cardinal Health, Labcorp and Align Technology
Zacks Industry Outlook Highlights Cardinal Health, Labcorp and Align Technology

For Immediate Release

Chicago, IL – May 14, 2025 – Today, Zacks Equity Research discusses Cardinal Health CAH, Labcorp LH and Align Technology ALGN

Industry: Dental Supplies

Link: https://www.zacks.

Should You Add These 3 Top-Performing Mutual Funds to Your Portfolio?
Should You Add These 3 Top-Performing Mutual Funds to Your Portfolio?

Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.

How can you tell a good mutual

3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio
3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio

Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.

The easiest, most reliable way

Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?
Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?

There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.

The easiest, most

Riskified (RSKD) Q1 Earnings and Revenues Top Estimates
Riskified (RSKD) Q1 Earnings and Revenues Top Estimates

Riskified (RSKD) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.04 per share a year ago. These figures

Kolibri Global Energy Inc. (KGEI) Tops Q1 Earnings and Revenue Estimates
Kolibri Global Energy Inc. (KGEI) Tops Q1 Earnings and Revenue Estimates

Kolibri Global Energy Inc. (KGEI) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.09 per share a year

Zacks Industry Outlook Highlights CF Industries, Mosaic and Yara International
Zacks Industry Outlook Highlights CF Industries, Mosaic and Yara International

For Immediate Release

Chicago, IL – May 14, 2025 – Today, Zacks Equity Research discusses CF Industries Holdings, Inc. CF, The Mosaic Co. MOS and Yara International ASA YARIY.

Industry: Fertilizer

L

Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer
Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer

For Immediate Release

Chicago, IL – May 14, 2025 – The stocks in this week’s article are StoneCo Ltd. STNE, Centene Corp. CNC, CVS Health Corp. CVS and Pfizer Inc. PFE.

4 Value Picks to Ride the

Dynatrace (DT) Q4 Earnings and Revenues Surpass Estimates
Dynatrace (DT) Q4 Earnings and Revenues Surpass Estimates

Dynatrace (DT) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.30 per share. This compares to earnings of $0.30 per share a year ago. These figures

DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue Estimates
DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue Estimates

DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.20 per share a year ago. These figures

Best Income Stocks to Buy for May 14thPhoto, wide shot, wide-angle lens,  Coal company, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/0e838f13-fa33-4583-92e9-bf3375dacf70.png
Best Income Stocks to Buy for May 14th

Here are three stocks with buy rank and strong income characteristics for investors to consider today, May 14th:

Southwest Gas SWX: This regulated utility company that provides natural gas services

Nyxoah SA (NYXH) Reports Q1 Loss, Lags Revenue Estimates
Nyxoah SA (NYXH) Reports Q1 Loss, Lags Revenue Estimates

Nyxoah SA (NYXH) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.49. This compares to loss of $0.45 per share a year ago. These figures are

Palantir Stock Rallies 69% in a Year: Is the Upside Already Priced in?
Palantir Stock Rallies 69% in a Year: Is the Upside Already Priced in?

Palantir Technologies Inc. PLTR has surged 69% year to date, significantly outperforming the 5% growth of the industry. This performance stands out when many tech giants are struggling to regain

Best Momentum Stock to Buy for May 14thPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
Best Momentum Stock to Buy for May 14th

Here is the stock with buy rank and strong momentum characteristics for investors to consider today, May 14th:

BrightSpring Health Services, Inc. BTSG: This parent company of healthcare service

LuxExperience B.V. - Sponsored ADR (LUXE) Surpasses Q3 Earnings Estimates
LuxExperience B.V. - Sponsored ADR (LUXE) Surpasses Q3 Earnings Estimates

LuxExperience B.V. - Sponsored ADR (LUXE) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to earnings of $0.05

European Wax Center, Inc. (EWCZ) Surpasses Q1 Earnings and Revenue Estimates
European Wax Center, Inc. (EWCZ) Surpasses Q1 Earnings and Revenue Estimates

European Wax Center, Inc. (EWCZ) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.13 per share a year